Clinical Trial

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2024-09-17; most recent amendment 2026-06-22.
Status change: Not Yet Recruiting → Recruiting 2026-01-19
Trial Details
NCT Number NCT06604884
Lead Sponsor Medtronic Neurovascular Clinical Affairs
Conditions Intracranial Aneurysm
Enrollment 118 participants
Start Date 2025-12-12
Primary Completion 2029-08 (estimated)
Study Completion 2033-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-12